Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty
Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty
Deep vein thrombosis (DVT) remains a life-threatening complication of arthroplasty. It
 remains controversial for anticoagulation strategies after total hip arthroplasty (THA). A
 randomized double-blind study was conducted to determine whether prophylactic anticoagulation
 was efficient reduce DVT after THA. subjects who underwent uncemented THA were assigned to
 prophylactic anticoagulation group or non- prophylactic anticoagulation group. Patients were
 followed up 3 months later after surgery. DVT was tested by contrast venography. Investigator
 also used logistic regression analysis with variable selection for obtaining the prediction
 model of DVT. DVT after THA was affected by personal (age) and clinical factors (mechanical
 compression, duration of surgery). THA with short duration of surgery did not require
 prophylactic anticoagulation.
Inclusion Criteria:

 -  Primary total hip arthroplasty

 Exclusion Criteria:

 -  Revision hip replacement, total knee replacement, revision knee replacement, semi-hip
 replacement and cemented THR were excluded.

 -  Coagulation related disease and cancer were excluded either.